Detalhe da pesquisa
1.
Estimated Lifetime Cardiovascular, Kidney, and Mortality Benefits of Combination Treatment With SGLT2 Inhibitors, GLP-1 Receptor Agonists, and Nonsteroidal MRA Compared With Conventional Care in Patients With Type 2 Diabetes and Albuminuria.
Circulation
; 149(6): 450-462, 2024 02 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-37952217
2.
Dapagliflozin and Blood Pressure in Patients with Chronic Kidney Disease and Albuminuria.
Am Heart J
; 270: 125-135, 2024 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-38367893
3.
Effects of Dapagliflozin in Chronic Kidney Disease Across the Spectrum of Age and by Sex.
J Gen Intern Med
; 39(6): 921-930, 2024 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-38097862
4.
Post hoc analysis of the SONAR trial indicates that the endothelin receptor antagonist atrasentan is associated with less pain in patients with type 2 diabetes and chronic kidney disease.
Kidney Int
; 104(6): 1219-1226, 2023 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-37657768
5.
Preparing European Nephrology for the next pandemic: lessons from the ERACODA collaboration.
Nephrol Dial Transplant
; 38(3): 575-582, 2023 02 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-36385300
6.
Urinary albumin excretion and cancer risk: the PREVEND cohort study.
Nephrol Dial Transplant
; 38(12): 2723-2732, 2023 Nov 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-37226556
7.
Estimated lifetime benefit of novel pharmacological therapies in patients with type 2 diabetes and chronic kidney disease: A joint analysis of randomized controlled clinical trials.
Diabetes Obes Metab
; 25(11): 3327-3336, 2023 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-37580309
8.
Timing of cardiac surgery during pregnancy: a patient-level meta-analysis.
Eur Heart J
; 43(29): 2801-2811, 2022 08 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35560020
9.
Effect of dapagliflozin on kidney and cardiovascular outcomes by baseline KDIGO risk categories: a post hoc analysis of the DAPA-CKD trial.
Diabetologia
; 65(7): 1085-1097, 2022 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-35445820
10.
Initiation of the SGLT2 inhibitor canagliflozin to prevent kidney and heart failure outcomes guided by HbA1c, albuminuria, and predicted risk of kidney failure.
Cardiovasc Diabetol
; 21(1): 194, 2022 09 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-36151557
11.
The Clinical Frailty Scale as a triage tool for ICU admission of dialysis patients with COVID-19: an ERACODA analysis.
Nephrol Dial Transplant
; 37(11): 2264-2274, 2022 10 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-36002034
12.
Recovery of dialysis patients with COVID-19: health outcomes 3 months after diagnosis in ERACODA.
Nephrol Dial Transplant
; 37(6): 1140-1151, 2022 05 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-35030246
13.
Quételet (body mass) index and effects of dapagliflozin in chronic kidney disease.
Diabetes Obes Metab
; 24(5): 827-837, 2022 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-34984791
14.
The radiological interpretation of possible microbleeds after moderate or severe traumatic brain injury: a longitudinal study.
Neuroradiology
; 64(6): 1145-1156, 2022 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-34719725
15.
Time trends in the risk of delayed cerebral ischemia after subarachnoid hemorrhage: a meta-analysis of randomized controlled trials.
Neurosurg Focus
; 52(3): E2, 2022 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-35231892
16.
Effects of Dapagliflozin in Stage 4 Chronic Kidney Disease.
J Am Soc Nephrol
; 32(9): 2352-2361, 2021 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-34272327
17.
Clinical triage of patients on kidney replacement therapy presenting with COVID-19: an ERACODA registry analysis.
Nephrol Dial Transplant
; 36(12): 2308-2320, 2021 12 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-34129039
18.
COVID-19-related mortality in kidney transplant and haemodialysis patients: a comparative, prospective registry-based study.
Nephrol Dial Transplant
; 36(11): 2094-2105, 2021 11 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-34132811
19.
Factors Influencing Speech Perception in Adults With a Cochlear Implant.
Ear Hear
; 42(4): 949-960, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-33480623
20.
Salt, but not protein intake, is associated with accelerated disease progression in autosomal dominant polycystic kidney disease.
Kidney Int
; 98(4): 989-998, 2020 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-32534051